Revenue · 2012–2025
Catalyst Pharmaceuticals revenue
$589M+19.8% · FY2025
Catalyst Pharmaceuticals (CPRX) reported $589M in revenue for fiscal 2025, +19.8% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $589M | +19.8% | Open → |
| FY20242024-12-31 | $492M | +23.5% | Open → |
| FY20232023-12-31 | $398M | +85.9% | Open → |
| FY20222022-12-31 | $214M | +52.1% | Open → |
| FY20212021-12-31 | $141M | +18.3% | Open → |
| FY20202020-12-31 | $119M | +16.4% | Open → |
| FY20192019-12-31 | $102M | +20,361.3% | Open → |
| FY20182018-12-31 | $500,000 | +$500,000 | Open → |
| FY20172017-12-31 | $0 | $0 | Open → |
| FY20162016-12-31 | $0 | $0 | Open → |
| FY20152015-12-31 | $0 | $0 | Open → |
| FY20142014-12-31 | $0 | $0 | Open → |
| FY20132013-12-31 | $0 | $0 | Open → |
| FY20122012-12-31 | $0 | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Catalyst Pharmaceuticals revenue |url=https://companiesranked.com/en/company/catalyst-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Catalyst Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/catalyst-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-catalyst-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Catalyst Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/catalyst-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-071525 · February 25, 2026
{{cite web |title=Catalyst Pharmaceuticals revenue — 10-K (0001193125-26-071525) |url=https://www.sec.gov/Archives/edgar/data/1369568/000119312526071525/cprx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.